If I Could Use Gene Therapy to Cure My Manic-Depression, I Don’t Know Whether I Would
By Tana Wojczuk,
Slate
| 09. 21. 2021
In the final chapter of her 1995 memoir of manic-depression, An Unquiet Mind, Kay Redfield Jamison posed a question that has stayed on my mind ever since: “I have often asked myself whether, given the choice, I would choose to have manic-depressive illness.” The question haunts me because I can’t answer it, either.
When Jamison first posed her question (if there were a cure for my mental illness, would I take it?), it seemed like pure speculation. But the question is no longer so hypothetical.
In June, the journal Nature Reviews Neurology published the results of a wide-ranging study of the genetic roots of manic depression. The study included 40,000 cases and identified a startling 64 genes associated with the disease. (In a clinical setting, the disease is usually referred to as “bipolar disorder,” though I’ve always preferred the more descriptive “manic-depression.”) Studies like this one are part of a burgeoning discipline known as molecular psychiatry, a field that studies the “biological mechanisms underlying psychiatric disorders.” Molecular biologists are also making progress in studies of major (unipolar)...
Related Articles
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Simar Bajaj, The New York Times | 11.27.2025
A common cold was enough to kill Cora Oakley.
Born in Morristown, N.J., with virtually no immune system, Cora was diagnosed with severe combined immunodeficiency, a rare genetic condition that leaves the body without key white blood cells.
It’s better...
